Towards Precision Medicine in Sinonasal Tumors: Low-Dimensional Radiomic Signature Extraction from MRI
- PMID: 40647674
- PMCID: PMC12248528
- DOI: 10.3390/diagnostics15131675
Towards Precision Medicine in Sinonasal Tumors: Low-Dimensional Radiomic Signature Extraction from MRI
Abstract
Background: Sinonasal tumors are rare, accounting for 3-5% of head and neck neoplasms. Machine learning (ML) and radiomics have shown promise in tumor classification, but current models lack detailed morphological and textural characterization. Methods: This study analyzed MRI data from 145 patients (76 malignant and 69 benign) across multiple centers. Radiomic features were extracted from T1-weighted (T1-w) images with contrast and T2-weighted (T2-w) images based on manually annotated tumor volumes. A dedicated ML pipeline assessed the effectiveness of different radiomic features and their integration with clinical variables. The DNetPRO algorithm was used to extract signatures combining radiomic and clinical data. Results: The results showed that ML classification using both data types achieved a median Matthews Correlation Coefficient (MCC) of 0.60 ± 0.07. The best-performing DNetPRO models reached an MCC of 0.73 (T1-w + T2-w) and 0.61 (T1-w only). Key clinical features included symptoms and tumor size, while radiomic features provided additional diagnostic insights, particularly regarding gray-level distribution in T2-w and texture complexity in T1-w images. Conclusions: Despite its potential, ML-based radiomics faces challenges in clinical adoption due to data variability and model diversity. Standardization and interpretability are crucial for reliability. The DNetPRO approach helps explain feature importance and relationships, reinforcing the clinical relevance of integrating radiomic and clinical data for sinonasal tumor classification.
Keywords: feature selection; machine learning; medical image analysis; otorhinolaryngology; radiomic.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
From pixels to prognosis: leveraging radiomics and machine learning to predict IDH1 genotype in gliomas.Neurosurg Rev. 2025 Apr 29;48(1):396. doi: 10.1007/s10143-025-03515-z. Neurosurg Rev. 2025. PMID: 40299088 Free PMC article.
-
Differentiation of Glioblastoma and Solitary Brain Metastasis Using Brain-Tumor Interface Radiomics Features Based on MR Images: A Multicenter Study.Acad Radiol. 2025 Jul;32(7):4164-4176. doi: 10.1016/j.acra.2025.04.008. Epub 2025 Apr 24. Acad Radiol. 2025. PMID: 40280830
-
Exploring the associations between features from multi-parametric MR images in Glioblastoma using radiomics.BMC Med Imaging. 2025 Jul 1;25(1):253. doi: 10.1186/s12880-025-01788-w. BMC Med Imaging. 2025. PMID: 40596920 Free PMC article.
-
The Machine Learning Models in Major Cardiovascular Adverse Events Prediction Based on Coronary Computed Tomography Angiography: Systematic Review.J Med Internet Res. 2025 Jun 13;27:e68872. doi: 10.2196/68872. J Med Internet Res. 2025. PMID: 40513092 Free PMC article.
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
References
-
- Luong T.T., Yan C.H. Benign Paranasal Sinus Tumors. Curr. Otorhinolaryngol. Rep. 2023;11:332–343. doi: 10.1007/s40136-023-00466-1. - DOI
-
- Bracigliano A., Tatangelo F., Perri F., Di Lorenzo G., Tafuto R., Ottaiano A., Clemente O., Barretta M.L., Losito N.S., Santorsola M., et al. Malignant Sinonasal Tumors: Update on Histological and Clinical Management. Curr. Oncol. 2021;28:2420–2438. doi: 10.3390/curroncol28040222. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources